drugset / Trial / NCT00239785

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

NCT00239785

Phase 3 Completed 684 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the safety and efficacy of FTY720 combined with cyclosporine and corticosteroids in patients receiving a kidney organ transplant

Timeline

Start
2003-04
Primary completion
2005-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Fingolimod Small molecule

Indications

No indication recorded.